论文部分内容阅读
目的:分析华蟾素注射液在食管癌患者中的应用效果及对血清相关指标的影响。方法:选取本院收治的90例食管癌患者为研究对象,将90例食管癌患者随机分为对照组(常规食管癌化疗组)45例和观察组(常规化疗加华蟾素注射液组)45例,然后将两组治疗前后的血清肿瘤标志物水平及其他血清疾病相关指标进行比较。结果:观察组治疗1、2、3个疗程后的血清肿瘤标志物水平及其他血清疾病相关指标均低于对照组,差异具有统计学意义(P<0.05)。结论:华蟾素注射液在食管癌患者中的应用效果较好,且可有效地控制血清相关指标。
Objective: To analyze the effect of cinobufagin injection on patients with esophageal cancer and its influence on serum related indexes. Methods: Ninety patients with esophageal cancer admitted to our hospital were enrolled in this study. Ninety patients with esophageal cancer were randomly divided into control group (conventional esophageal cancer chemotherapy group) and observation group (conventional chemotherapy plus cinobufagin injection group) 45 cases, and then compare the levels of serum tumor markers before and after treatment and other serum disease-related indicators. Results: The levels of serum tumor markers and other serum diseases in observation group were lower than those in control group after treatment for 1, 2, and 3 courses, with statistical significance (P <0.05). Conclusion: The application of cinobufacini injection in patients with esophageal cancer is effective and can effectively control serum related indicators.